BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2020

View Archived Issues

If a tree stings in the wood, it's with a peptide

Read More

XBiotech is developing Fluvid as novel treatment for influenza and COVID-19 coinfections

Read More

Nocion Therapeutics presents new SCN9A blockers

Read More

Roche synthesizes new antibacterial compounds

Read More

FronThera US Pharmaceuticals discloses TYK2 inhibitors

Read More

Genhouse Medicine identifies PTPN11 inhibitors

Read More

FDA clears IND for phase I trial of Emmecell's EO-2002 for corneal edema

Read More

Arthritis is different disease with antibodies than without

Read More

First data for the anti-CD73 oleclumab in triple-negative breast cancer

Read More

Results presented for ipatasertib plus abiraterone in mCRPC

Read More

Vaccination with a centrin KO Leishmania major strain is safe, immunogenic and disease-protective

Read More

Circulating DPP3 inhibition restores cardiac function during sepsis in CLP rat models

Read More

Japanese phase III study of Avigan shows promise in patients with COVID-19

Read More

First healthy volunteers dosed in phase I study of MORF-057

Read More

FDA allows IND application for TCRT-ESO-A2

Read More

Cytokinetics initiates phase I study of CK-3772271

Read More

Using tumor organoids, researchers identify recurrent, druggable neuroblastoma targets

Read More

MIL-62 demonstrates promising safety and efficacy in CD20-positive B-cell NHL

Read More

Janssen's COVID-19 vaccine candidate JNJ-78436735 enters phase III

Read More

Ensifentrine enters phase III trials for moderate to severe COPD

Read More

Millendo begins first-in-human study of MLE-301 for vasomotor symptoms in menopausal women

Read More

First-in-human data reported for MGD-019

Read More

Phase I data on NMT-cP12 support progression to phase II for severe burns

Read More

Japanese approval for Jyseleca in rheumatoid arthritis

Read More

Genfit begins phase III study of elafibranor in primary biliary cholangitis

Read More

Phase II study of semorinemab in early Alzheimer's misses key efficacy endpoints

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing